NewsBot
10-Nov-20, 00:12
The Caithness Business Index (http://www.caithness-business.co.uk) has posted the following article:
Albert Bourla From Pfizer Discusses Covid-19 Vaccine Efficacy Results
https://caithness-business.co.uk/image_cache/na12279_tn.jpg
I am happy to share with you that Pfizer and our collaborator, BioNTech, announced positive efficacy results from our Phase 3, late-stage study of our potential COVID-19 vaccine. The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis. [Read Full Article (https://caithness-business.co.uk/article/12279)]
Albert Bourla From Pfizer Discusses Covid-19 Vaccine Efficacy Results
https://caithness-business.co.uk/image_cache/na12279_tn.jpg
I am happy to share with you that Pfizer and our collaborator, BioNTech, announced positive efficacy results from our Phase 3, late-stage study of our potential COVID-19 vaccine. The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis. [Read Full Article (https://caithness-business.co.uk/article/12279)]